Lead-in period (2 weeks) | Isoenergetic period (2 weeks) | Ad libitum period (12 weeks) | Friedman tests | ||
---|---|---|---|---|---|
Physical activity (MET-h/d)*: | |||||
Control group (n = 13) | 38.2 (19.9) | 38.6 (22.7) | 37.4 (21.7) | χ2(5) = 6.156, p = 0.291 | |
n-3-PUFA3 group (n = 13) | 54.8 (29.9) | 62.0 (29.9) | 57.5 (29.6) | χ2(5) = 7.313, p = 0.198 | |
RM-ANOVA† | |||||
Time | Time × Group | ||||
Calorie intake (MJ/d): | |||||
Control group (n = 13) | 10.9 (1.5) | 10.9 (1.3) | 10.2 (1.9) | F(1.1,26.4) = 2.994, | F(1.1,26.4) = 0.703, |
n-3-PUFA group (n = 13)‡ | 11.0 (2.2) | 11.1 (2.0) | 10.7 (2.5) | p = 0.092 | p = 0.555 |
CRC 1 § | CRC 2 | CRC 3 | |||
Resting energy expenditure (MJ/d): | |||||
Control group (n = 12) | 6.74 (0.89) | 6.41 (1.10) | 6.41 (0.79) | F(2,46) = 0.313, | F(2,46) = 0.703, |
n-3-PUFA group (n = 13) | 6.53 (1.23) | 6.59 (1.51) | 6.57 (1.39) | p = 0.733 | p = 0.500 |
Resting energy expenditure (kJ/d/kg fat free body mass ||): | |||||
Control group (n = 12) | 134 (15) | - | 132 (13) | F(1,23) = 0.002, | F(1,23) = 0.315, |
n-3-PUFA group (n = 13) | 133 (21) | - | 135 (14) | p = 0.961 | p = 0.580 |
Respiratory quotient: | |||||
Control group (n = 12) | 0.86 (0.05) | 0.87 (0.05) | 0.86 (0.05) | F(2,46) = 0.096, | F(2,46) = 1.091, |
n-3-PUFA group (n = 13) | 0.85 (0.03) | 0.84 (0.05) | 0.85 (0.05) | p = 0.908 | p = 0.344 |